Medical News

RSS

Two large health insurers extend coverage to young adults

The Wall Street Journal / Dow Jones: Two large U.S. health insurers have announced plans "to keep young adults on their parents' policies before a new law requiring such action goes into effect, and the government is working to get others to do the same. Health and Human Services Secretary Kathleen Sebelius, citing the insurers' moves, said Monday her department is 'working hard with other insurers on similar proposals' and sent letters offering to assist them in such efforts.

20 Apr 2010

Pharmacists Mutual Insurance selects Interactive Intelligence's CIC to support employees

Pharmacists Mutual Insurance Company has selected the Interactive Intelligence all-in-one IP communications software suite, Customer Interaction Center, to support its on-site and branch office employees.

20 Apr 2010

Exercise machine for lumbago

Low back pain (or lumbago) is a common ailment often triggered by something as simple as lifting a suitcase. What is the best way to remedy the situation? An exercise machine designed specifically for back muscles could be the solution according to a new study published in the Journal of the American College of Sports Medicine.

20 Apr 2010

Panel to save Medicare costs irks lawmakers

A Medicare panel meant to help lawmakers make tough choices about cutting costs in the program has drawn bipartisan ire, Bloomberg BusinessWeek reports.

20 Apr 2010

LSF gene plays important role in development and progression of HCC: VCU researchers

Virginia Commonwealth University researchers have identified a new tumor-promoting gene that may play a key role in the development of liver cancer. Levels of the gene's expression are significantly higher in more than 90 percent of patients with the disease compared to their healthy counterparts.

20 Apr 2010

ICU Medical's first-quarter revenue up 18.5%

ICU Medical, Inc.,, a leading low cost manufacturer of safe medical connectors, custom medical products and critical care devices, announced results for the first quarter ended March 31, 2010.

20 Apr 2010

Obama camp, industry shift from political battle to implementation focus

President Barack Obama's administration is shifting its focus from the politics of the health overhaul to the work of implementing it, which officials may pursue even more quickly than required by the law, The New York Times reports. Top health officials, including Health and Human Services Secretary Kathleen Sebelius, White House adviser Pete Rouse, and Obama's health care lobbyist Nancy-Ann DeParle will all play central roles in implementing the law.

20 Apr 2010

Gilead Sciences halts Phase II trial of GS 9450 for chronic hepatitis C

Gilead Sciences, Inc. today announced the company is stopping its ongoing Phase II clinical trial of GS 9450, an investigational caspase inhibitor, in patients with chronic hepatitis C. This decision follows reports of significant laboratory abnormalities and adverse events in a number of clinical study participants.

20 Apr 2010

Health care a key factor in some congressional races

USA Today: "In an election year dominated by health care, dozens of candidates for Congress have a catchy campaign slogan at their disposal: Send a doctor to the House. Forty-seven physicians — 41 Republicans and six Democrats — are running for the House or Senate this year, three times the number of doctors serving in Congress today, according to a USA TODAY review" (Fritze, 4/19).

20 Apr 2010

EpiCept announces U.K. launch of Ceplene

EpiCept Corporation today announced that the commercial launch of Ceplene® (histamine dihydrochloride) will take place in the United Kingdom on April 20, 2010 in conjunction with the British Society for Haematology 50th Annual Scientific Meeting in Edinburgh, Scotland. Ceplene is approved in the European Union for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first remission.

20 Apr 2010

HAMLET substance found in breast milk can kill cancer cells: Researchers

A substance found in breast milk can kill cancer cells, reveal studies carried out by researchers at Lund University and the University of Gothenburg, Sweden.

20 Apr 2010

Consumers: How will health reform affect insurance premiums?

Las Vegas Sun: "Like many other Las Vegas Valley residents, Yvette Williams is hoping the new national health insurance law will choke down the siphoning of money from her family's budget." The family spends $12,000 a year on health care. "Because the new national health insurance law is supposed to give consumers more ways to get insurance, it's expected to force industry giants to offer more comprehensive plans at lower prices" (Kanigher, 4/19).

20 Apr 2010

Agilent Technologies introduces user-friendly genomics Web site

Agilent Technologies Inc. today introduced a dynamic and user-friendly genomics Web site, genomics.agilent.com.

20 Apr 2010

Bruker launches new compact, high field NMR magnet series

At the 51st ENC, Bruker launches its new Ascend™ series of compact, high field NMR magnets to make high-field NMR even more powerful, and at the same time more convenient and accessible for numerous NMR laboratories. This new magnet line combines the key advantages of Bruker's well-established UltraShield™ Plus magnets, with further innovations for superior performance and greater convenience.

20 Apr 2010

Higher intake of vitamin K from dietary sources associated with lower risk of Non-Hodgkin lymphoma

In the first study of vitamin K and Non-Hodgkin lymphoma risk, researchers at the Mayo Clinic campus in Minnesota have found that people who have higher intakes of vitamin K from their diet have a lower risk of developing Non-Hodgkin lymphoma.

20 Apr 2010

White House officially names Berwick as pick to head CMS

"President Barack Obama has nominated Harvard medical professor Donald Berwick to oversee Medicare and Medicaid. Obama had signaled his plans in March and made them official Monday." The nomination must be confirmed by the Senate (4/19).

20 Apr 2010

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

19 Apr 2010

OECs may hold promise for pediatric cerebral palsy treatment

A unique cell type that supports and surrounds (ensheathes) neurons within the nose (olfactory system) known as olfactory ensheathing cells (OECs), possess the ability to regenerate, are relatively easy to obtain, and have become prime candidates for transplantation to repair a number of lesions in the central nervous system (CNS).

19 Apr 2010

SPI-Bio to distribute and sell Aterovax's sPLA2 activity test in Europe

Aterovax SA, a company developing innovative products for atherosclerosis, today announced the signing of a 3 year, exclusive agreement with SPI-Bio, a specialist distributor of products and services in drug development, to distribute and sell Aterovax's sPLA2 activity test in Europe to academic and research laboratories for research use.

19 Apr 2010

Today's OpEds: Heritage disputes Obama's claims on health law; Florida nursing home reforms in danger

Think tank analysts usually brim with pride when the president of the United States goes around claiming that his policies are based on their work. But when President Obama tries to sell his health-care law as a moderate approach that borrows ideas developed by the Heritage Foundation, we get incensed (Robert Moffit, 4/19).

19 Apr 2010